Executive Roundtable at the Danish Embassy in Sweden

The future is digital: Ensure compliance efforts enable your business goals

January 24, 2018
Residence of the Danish Embassy

This event is co-sponsored by the Embassy of Denmark in Sweden. Participation by invitation only. 
If you, as a Life Science executive, have not received an invitation and feel that you could benefit from this program, please contact us at [email protected].


Life Science companies are constantly bombarded with new regulations, new technology and new business initiatives. They must find the optimal balance between risk and efficiency so that regulatory compliance enables digitalization, analytics, patient-centricity, and more.

Executive are asking serious questions:
- Are we over-spending on time and resources, hampering efficiency and our bottom line?
- Are we underspending, running the risk of out-of-control compliance?

This Executive Roundtable will explore the results of a new benchmarking study that gives a snapshot of compliance maturity in the Danish Life Science industry. The study sheds light on important industry challenges and trends - and makes concrete recommendations for companies to achieve optimal balance between risk and efficency. Where does your company fall on the compliance maturity scale? Is your compliance optimal?

We will discuss results & insights from the study and you will get inspiration to assess your own compliance maturity - and ultimately make your compliance efforts more transparent, predictable and efficient - leading your company into the digital future.

This event is co-sponsored by the Embassy of Denmark in Sweden. Participation by invitation only. 
If you, as a Life Science executive, have not received an invitation and feel that you could benefit from this program, please contact us at [email protected]om.

Program:
07:45
Registration and Networking

08:00
Light Network Breakfast

08:30
Welcome
Ove Ullerup, Danish Ambassador to Sweden

08:40
Explore the results of the new study: 2017 Benchmark of Compliance Maturity
Klavs Esbjerg, CEO, Epista Life Science
Robert Pettersson, Managing Director, Epista Life Science - Sweden

09:30
Thanks for today